Key Highlights
- AEHR shares climbed 15.41% Thursday following the announcement of a landmark $41 million production contract from a hyperscale client.
- The contract involves package-level burn-in testing for custom AI processor ASICs utilizing Aehr’s Sonoma high-power platforms.
- Shipments are scheduled to commence in fiscal 2027, beginning June 27, 2026.
- An insider transaction saw a director offload $1.21 million worth of shares on April 16, one day prior to the public announcement.
- Analysts maintain a Strong Buy rating with a consensus price target of $62.
Aehr Test Systems secured its largest contract ever on Thursday, triggering significant investor enthusiasm. The semiconductor testing specialist revealed a $41 million production agreement with its primary hyperscale client for package-level burn-in testing of custom AI processor ASICs. AEHR shares rallied 15.41% following the disclosure.
The contract encompasses a substantial quantity of Aehr’s Sonoma high-power package-level testing and burn-in platforms. Additionally, it incorporates turnkey burn-in modules along with device-specific sockets designed to customize the systems for particular AI processors.
This represents a repeat order, indicating the hyperscale client — whose name remains undisclosed — has established history with Aehr. The agreement strengthens an already expanding business relationship.
Shipments are scheduled to commence during Aehr’s fiscal 2027, which begins on June 27, 2026. This timeline provides the company with predictable near-term revenue visibility.
Chief Executive Gayn Erickson emphasized that additional opportunities remain on the horizon. He highlighted that the same customer is currently developing a next-generation, higher-power AI accelerator ASIC scheduled to enter production later in the year.
Aehr has already secured an initial purchase order from this client for several Sonoma systems to facilitate production of the advanced chip. This suggests the $41 million agreement may represent merely the opening chapter of a much larger revenue stream.
“As these next-generation devices move into volume production, we see the potential for further substantial increases in demand for Sonoma systems and consumables in our next fiscal year,” Erickson said.
Impressive Performance Leading Up to Major Announcement
Thursday’s rally continues an extraordinary upward trajectory for AEHR. Year-to-date, the stock has surged 246.95%, while the trailing twelve-month period shows gains of 805.07%.
Trading volume exceeded 1.75 million AEHR shares on Thursday, approaching the three-month average daily volume of approximately 2.77 million.
The historic contract announcement follows solid fiscal Q3 2026 performance. Revenue reached $10.3 million, marginally below the $10.8 million projection, yet the company achieved record quarterly bookings of $37.2 million. This performance elevated the order backlog above $50 million.
Regarding earnings per share, Aehr outperformed expectations — delivering -$0.05 versus the anticipated -$0.07.
Wall Street Coverage and Insider Transactions
Financial analysts have been revising their projections upward. Freedom Broker increased its price objective to $61 from $38 while retaining a Hold recommendation. Lake Street elevated its target to $56 from $50, pointing to robust booking trends, and maintained its Buy stance.
Wall Street’s overall assessment stands at Strong Buy, with three Buy recommendations issued during the past three months. The consensus price target of $62 suggests approximately 26.67% potential upside from present levels.
Regarding insider activity, Director Rhea J. Posedel divested 15,000 shares on April 16 at $80.72 each, generating proceeds of $1.21 million. After this transaction, Posedel maintains direct ownership of 71,163 shares, plus an additional 411,979 shares held indirectly via trust.





